O'Farrell Elizabeth G. 4
4 · Inhibikase Therapeutics, Inc. · Filed Jun 28, 2022
Insider Transaction Report
Form 4
O'Farrell Elizabeth G.
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-24+40,000→ 40,000 totalExercise: $0.81Exp: 2029-06-24→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]This entire stock option grant will vest 100% in a single tranche on the earlier of June 24, 2023 or the day prior to the next annual meeting of stockholders.